Urotensin II in the cardiovascular system

被引:42
作者
Richards, AM [1 ]
Charles, C [1 ]
机构
[1] Christchurch Sch Med & Hlth Sci, Dept Med, Christchurch Cardioendocrine Res Grp, Christchurch, New Zealand
关键词
urotensin II vasoactivity; urotensin II in isolated vessels; urotensin administered to man;
D O I
10.1016/j.peptides.2004.04.017
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Urotensin II is a peptide present, together with its receptor, in the central nervous system and many peripheral tissues (including heart, blood vessels, kidneys and endocrine organs) of many species. The bioactive, mature form contains a cyclic heptapeptide perfectly preserved across species spanning 550 million years of evolution Its biological activity has been explored in cultured cells, in isolated vessels from several species, in the isolated perfused heart and in intact animals and man. Initial demonstration of potent vasoconstriction and cardiac depression by the human isoform in non-human primates has been followed by a series of reports indicating potent but highly variable and generally modest vascular responses dependent on species and vascular region. In man short term cardiovascular responses to administered urotensin II are small or absent. The place of urotensin II in the chronic trophic responses to cardiac and vascular injury and its possible roles as a neurotransmitter and/or regulator of renal and endocrine function remain largely unexplored. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:1795 / 1802
页数:8
相关论文
共 48 条
[1]
Involvement of the nitric oxide/L-arginine and sympathetic nervous systems on the vasodepressor action of human urotensin II in anesthetized rats [J].
Abdelrahman, AM ;
Pang, CCY .
LIFE SCIENCES, 2002, 71 (07) :819-825
[2]
No effect on central or peripheral blood pressure of systemic urotensin II infusion in humans [J].
Affolter, JT ;
Newby, DE ;
Wilkinson, IB ;
Winter, MJ ;
Balment, RJ ;
Webb, DJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 54 (06) :617-621
[3]
Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 [J].
Ames, RS ;
Sarau, HM ;
Chambers, JK ;
Willette, RN ;
Alyar, NV ;
Romanic, AM ;
Louden, CS ;
Foley, JJ ;
Sauermelch, CF ;
Coatney, RW ;
Ao, ZH ;
Disa, J ;
Holmes, SD ;
Stadel, JM ;
Martin, JD ;
Liu, WS ;
Glover, GI ;
Wilson, S ;
McNulty, DE ;
Ellis, CE ;
Elshourbagy, NA ;
Shabon, U ;
Trill, JJ ;
Hay, DWP ;
Ohlstein, EH ;
Bergsma, DJ ;
Douglas, SA .
NATURE, 1999, 401 (6750) :282-286
[4]
Deletion of the UT receptor gene results in the selective loss of urotensin-II contractile activity in aortae isolated from UT receptor knockout mice [J].
Behm, DJ ;
Harrison, SM ;
Ao, ZH ;
Maniscalco, K ;
Pickering, SJ ;
Grau, EV ;
Woods, TN ;
Coatney, RW ;
Doe, CPA ;
Willette, RN ;
Johns, DG ;
Douglas, SA .
BRITISH JOURNAL OF PHARMACOLOGY, 2003, 139 (02) :464-472
[5]
Urotensin II evokes potent vasoconstriction in humans in vivo [J].
Böhm, F ;
Pernow, J .
BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135 (01) :25-27
[6]
Human urotensin-II is an endothelium-dependent vasodilator in rat small arteries [J].
Bottrill, FE ;
Douglas, SA ;
Hiley, CR ;
White, R .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 130 (08) :1865-1870
[7]
Effects of human urotensin II in isolated vessels of various species;: comparison with other vasoactive agents [J].
Camarda, V ;
Rizzi, A ;
Calò, G ;
Gendron, G ;
Perron, SI ;
Kostenis, E ;
Zamboni, P ;
Mascoli, F ;
Regoli, D .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2002, 365 (02) :141-149
[8]
Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord [J].
Coulouarn, Y ;
Lihrmann, I ;
Jegou, S ;
Anouar, Y ;
Tostivint, H ;
Beauvillain, JC ;
Conlon, JM ;
Bern, HA ;
Vaudry, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) :15803-15808
[9]
Human urotensin-II as a novel cardiovascular target: 'heart' of the matter or simply a fishy 'tail'? [J].
Douglas, SA .
CURRENT OPINION IN PHARMACOLOGY, 2003, 3 (02) :159-167
[10]
Congestive heart failure and expression of myocardial urotensin II [J].
Douglas, SA ;
Tayara, L ;
Ohlstein, EH ;
Halawa, N ;
Giaid, A .
LANCET, 2002, 359 (9322) :1990-1997